Department of Epidemiology and Preventative Medicine, Women's Health Research Program, School of Public Health and Preventative Medicine, Monash University, Melbourne, Victoria, Australia.
Clin Endocrinol (Oxf). 2021 Nov;95(5):752-759. doi: 10.1111/cen.14592. Epub 2021 Sep 15.
To document associations between anti-Müllerian hormone (AMH) and circulating androgens in nonhealthcare-seeking premenopausal women.
Community-based, cross-sectional study.
Eastern states of Australia.
Women aged 18-39 years not using systemic hormones, not pregnant or breastfeeding within 3 months, and not postmenopausal.
AMH, measured by the Beckman Access 2, 2 site immunometric assay from fresh samples, and testosterone, androstenedione, dehydroepiandrosterone (DHEA) and 11-oxygenated C19 steroids, measured by liquid chromatography-tandem mass spectrometry.
Data were available for 794 women, median age of 33 years (range: 18-39). 76.1% were of European ancestry and 48.2% were parous. Serum AMH was positively associated with testosterone (rho = .29, p < .001) androstenedione (rho = .39, p < .001) and DHEA (rho = .10, p = .005) but not 11-ketoandrostenedione or 11-ketotestosterone. When adjusted for age, body mass index and smoking, using quantile regression, independent positive associations remained between AMH and testosterone (β coefficient: 20.90, 95% confidence interval [CI]: 13.79-28.03; p < .001) and androstenedione (β coefficient: 5.90, 95% CI: 3.76-8.03; p < .001). The serum concentration of testosterone was greater at the top AMH quintile than other quintiles (0.56 nmol/L [range: 0.21-1.90] vs. 0.36 nmol/L [range: 0.13-0.87]; p = .001) in women with self-reported polycystic ovary syndrome.
The positive associations between serum testosterone and androstenedione and AMH in premenopausal women is consistent with androgens directly or indirectly influencing AMH production during follicular development. As the highest AMH concentrations are most likely to be seen in women with multifollicular ovaries, it would be expected that women with multifollicular ovaries would have higher serum testosterone. Therefore, whether hyperandrogenemia and multifollicular ovaries should be considered independent characteristics of polycystic ovary syndrome warrants review.
记录抗苗勒管激素(AMH)与非求医的绝经前女性循环雄激素之间的关联。
基于社区的横断面研究。
澳大利亚东部各州。
年龄在 18-39 岁之间、未使用全身激素、3 个月内未怀孕或哺乳、绝经后女性。
使用贝克曼 Access 2 新鲜样本 2 位点免疫测定法测量 AMH,使用液相色谱-串联质谱法测量睾酮、雄烯二酮、脱氢表雄酮(DHEA)和 11-氧代 C19 类固醇。
794 名女性的数据可用,中位年龄为 33 岁(范围:18-39)。76.1%为欧洲血统,48.2%为经产妇。血清 AMH 与睾酮(rho=0.29,p<0.001)、雄烯二酮(rho=0.39,p<0.001)和 DHEA(rho=0.10,p=0.005)呈正相关,但与 11-酮雄烯二酮或 11-酮睾酮无关。使用定量回归法,在调整年龄、体重指数和吸烟因素后,AMH 与睾酮(β系数:20.90,95%置信区间[CI]:13.79-28.03;p<0.001)和雄烯二酮(β系数:5.90,95% CI:3.76-8.03;p<0.001)之间仍存在独立的正相关关系。在报告有多囊卵巢综合征的女性中,血清睾酮浓度在 AMH 五分位数最高的五分位数中高于其他五分位数(0.56 nmol/L[范围:0.21-1.90]比 0.36 nmol/L[范围:0.13-0.87];p=0.001)。
在绝经前女性中,血清睾酮和雄烯二酮与 AMH 之间的正相关关系表明,雄激素直接或间接影响卵泡发育过程中的 AMH 产生。由于最高的 AMH 浓度最有可能出现在有多卵泡卵巢的女性中,因此预计有多卵泡卵巢的女性会有更高的血清睾酮。因此,是否应将高雄激素血症和多卵泡卵巢视为多囊卵巢综合征的独立特征,值得重新审视。